|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
OUTCOME STUDY SUMMARY
Most people interested in services at ACE want to know
if our program is successful. At
ACE, we conduct ongoing outcome research by collecting surveys from participants
before and after their treatment. Doing
so allows us to measure participants' progress and determine the effectiveness
of our treatment approach. Our most recent analysis included 77 participants who went through either the partial hospitalization
program (PHP) or intensive outpatient program (IOP) at ACE between 2001
and 2006. The number of weeks the participants were in the program ranged
from We give several questionnaires to participants at their initial assessment appointments and again at discharge from the program. The questionnaires are used to assess participants' eating disorder symptoms, depressive symptoms, and anxiety symptoms. The instruments used include the Eating Disorder Inventory- Second Edition (EDI-2; Garner, 1991), the Eating Disorder Inventory- Symptom Checklist (EDI-SC; Garner, 1991), the Beck Depression Inventory- Second Edition (BDI-II; Beck, Steer, & Brown, 1996), and the Sheehan Patient Rated Anxiety Scale (SPRAS; Sheehan, 1990). The participants' weight and use of eating disorder behaviors are also obtained weekly throughout treatment by the therapist or nutritionist Remarkably,
the comparison of scores in the analysis yielded significant reductions
on every variable measured! These outcomes are far above those found in published
studies in eating disorder journals (see International Journal of Eating
Disorders and Eating Disorders:
Prevention, Treatment and Research).
Specifically, participants reported a significantly lower
number of eating disordered symptoms, attitudes, personality features
such as body dissatisfaction, drive for thinness and perfectionism. Additionally, the analysis revealed a significant
reduction in depressive and anxiety symptoms. Table 1 shows the means (average scores) and
sample size for each of these comparisons. Table
1. Mean Differences
in Eating Disorder, Depressive, & Anxiety Symptoms Between Pre-Treatment
and Post-Treatment
Note. EDI-2 = Eating Disorder
Inventory-Second Edition; BDI-II = Beck Depression Inventory- Second Editioin; SPRAS = Sheehan Patient Rated Anxiety Scale. Participants experienced a significant reduction in eating
disorder symptoms. Thirty-one of
the women in the study reported experiencing binge eating episodes in
the initial assessment. Among these women, there was a significant decrease
in the average number of binges per week at the post-treatment assessment.
Thirty-one women in the sample reported using purging in the initial assessment.
Among these women, there was a significant decrease in the average
number of purges per week at the post-treatment assessment. The analysis
revealed a significant change in weight among the participants who were
anorexic. Among the participants who reported their weight at pre-treatment
and post-treatment, there was a statistically significant increase in
weight at post-treatment. These results suggest that ACE's treatment program is highly effective in decreasing eating disorder symptoms, depressive symptoms, and anxiety symptoms in an average of three months of treatment. The program effectively integrates evidence-based treatments (e.g., cognitive-behavioral therapy) with clinical experience and additional interventions designed to address individual differences. This study demonstrates hope and expectation that symptoms, complications and struggles of an eating disorder may be alleviated or significantly reduced with effective treatment in an outpatient setting.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008, ACE, all rights reserved. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||